Psyence Biomedical Ltd.
About
4.37USD+0.05 +1.16%
Closed • Updated at 13:17 GMT+00:00Market Cap$4.47M
Volume77.6K
Beta11.14
RSI44.26
Psyence Biomedical Ltd. — investor relations, events, news, and company updates on 6ix.
Latest News
May 15 2026
Psyence BioMed Announces U.S. Strategic Engagement Initiative Focused on GMP Ibogaine Research and Manufacturing
Apr 23 2026
Psyence BioMed Initiates Patient Dosing in Phase IIb Trial Evaluating NPX-5 for Adjustment Disorder
Apr 20 2026
Psyence BioMed Positioned as World's only Licensed Pharmaceutical Grade Ibogaine Supplier at Source
Apr 17 2026
Psyence BioMed Welcomes U.S. Executive Action to Advance Research into Ibogaine
Apr 14 2026
Pacific Bay & Aurwest Sign Weaver Gold Property Definitive Option/JV Agreement
Recent Videos
$PBM Will Explode If Ibogaine Gets Approved: How Joe Rogan Fast-Tracked It With Trump
May 28, 2026
NASDAQ: PBM 🚀 Psyence Biomedical Stock Ready To Explode?#PBM#PsyenceBiomedical #NASDAQ#StockAnalysis
May 20, 2026
PBM STOCK : STRONG PRICE JUMP | PSYENCE BIOMEDICAL STOCK
May 19, 2026
Undervalued Psychedelic Biotech with Phase IIb Data Coming in 2026 | Psyence Biomedical (PBM) Stock
May 05, 2026
Community Chat
Ask AI
Try asking